Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearside Biomedical

0.4972
-0.0416-7.72%
Post-market: 0.49720.00000.00%19:59 EDT
Volume:2.37M
Turnover:1.23M
Market Cap:38.64M
PE:-1.22
High:0.5470
Open:0.5400
Low:0.4800
Close:0.5388
Loading ...

Clearside Biomedical Is Maintained at Buy by Needham

Dow Jones
·
15 May

Clearside Biomedical Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Clearside Biomedical Q1 EPS $(0.11), Inline, Sales $2.33M Beat $170.00K Estimate

Benzinga
·
15 May

Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
13 May

Clearside Biomedical announces six presentations related to CLS-AX

TIPRANKS
·
09 May

Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
05 May

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

GlobeNewswire
·
01 May

Clearside Biomedical Price Target Maintained With a $4.00/Share by Needham

Dow Jones
·
08 Apr

Clearside Biomedical Inc (CLSD) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
02 Apr

Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
01 Apr

Clearside Biomedical Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Mar

Stifel Nicolaus Sticks to Its Buy Rating for Clearside Biomedical (CLSD)

TIPRANKS
·
29 Mar

Clearside Biomedical Price Target Maintained With a $5.00/Share by Citizens Capital Markets

Dow Jones
·
28 Mar

Clearside Biomedical Is Maintained at Buy by Needham

Dow Jones
·
28 Mar

Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
28 Mar

Clearside Biomedical Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Clearside Biomedical Reports 2024 Financial Results and Updates

TIPRANKS
·
28 Mar

Clearside Biomedical Q4 2024 GAAP EPS $(0.10), Inline, Sales $306.00K Beat $176.67K Estimate

Benzinga
·
28 Mar

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
28 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar